Who invested in Vicept Therapeutics?
Vicept Therapeutics's investors include F-Prime Capital, Sofinnova Investments, Vivo Ventures, Fidelity Biosciences and UCLA VC Fund.
United States · Series A startup
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2010, from 1 source
Reported by vicepttx.comSEC filing: $16M sold, first sale Aug 2009
From historical deal records. Wrong? Tell us.
Vicept Therapeutics's investors include F-Prime Capital, Sofinnova Investments, Vivo Ventures, Fidelity Biosciences and UCLA VC Fund.
Vicept Therapeutics has raised $16M across 1 round since 2010.
Vicept Therapeutics's most recent round was a Series A of $16M in Jun 2010.
Its most recent round, $16M in Jun 2010, is also its largest on record.
Vicept Therapeutics's first round on record, in Jun 2010, was backed by F-Prime Capital, Sofinnova Investments and Vivo Ventures and 2 others.
Vicept Therapeutics's latest named round is a Series A, in Jun 2010.
Vicept Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.